Skip to main content
. 2016 Summer;15(3):379–391.

Table 10.

Prediction result on artificial sample and commercial samples obtained with PLS1, PCR and HLA methods for loratadine. Concentration values are expressed as mgL−1.




Predicted

Sample No. Actual PLS1 PCR HLA
Art 1a 4.00 4.08±0.13 (102.00) b 4.08±0.13 (102.00) 4.06±0.21 (101.50)
Art 2 5.00 5.13±0.14 (102.60) 5.17±0.13 (103.40) 5.10±0.22 (102.00)
Art 3 9.00 8.96±.012 (99.56) 9.10±0.09 (101.11) 8.72±0.16 (96.89)
Art 4 10.00 10.08±0.14 (100.80) 10.08±0.14 (100.80) 10.02±0.21 (100.20)
Art 5 13.00 12.85±0.10 (98.84) 12.85±0.10 (98.84) 13.05±0.22 (100.38)
Art 6 10.00 10.29±0.09 (102.90) 10.28±.012 (102.80) 9.95±0.17 (99.50)
Art 7 4.00 4.02±0.14 (100.50) 4.12±0.11 (103.00) 4.00±0.13 (100.00)
Art 8
Unk 1 a
Unk 2
Unk 3
Unk 4
Unk 5
0.00
0.00
12.00
14.00
12.00
14.00
–0.12±0.10 (–)
–0.44±0.11 (–)
12.34±0.09 (102.83)
14.53±013 (103.78)
12.50±0.08 (104.17)
14.29±0.09 (102.07)
−0.17±0.15 (−)
−0.47±0.12 (−)
12.32±0.09 (102.67)
14.48±0.14 (103.42)
12.53±0.07 (104.42)
14.28±0.10 (101.86)
−0.05±0.13 (–)
−0.38±0.20 (–)
12.21±0.24 (101.75)
13.72±0.23 (98.00)
12.57±0.23 (104.75)
14.40±0.21 (102.86)
x̅ 101.82 102.12 100.71
a

Art is artificial samples and Unk is unknown samples.

b

The reported values of standard deviations (±S.D.) are obtained from four replicates. Recovery percentages are shown in parentheses.